Potential inhibitors of the interaction between ACE2 and SARS-CoV-2 (RBD), to develop a drug-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Potential inhibitors of the interaction between ACE2 and SARS-CoV-2 (RBD), to develop a drug

Published:2020-09 Issue: Volume:256 Page:117970
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Benítez-Cardoza Claudia Guadalupe,Vique-Sánchez José Luis

Funder

SIP

IPN

COFAA

IPN2

PRODEP

SEP

SNI

CONACyT

UABC

IPN3

IPN4

José Manuel Avendaño Reyes

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference42 articles.

1. SARS and MERS: recent insights into emerging coronaviruses;de Wit;Nat. Rev. Microbiol.,2016

2. Clinical characteristics of coronavirus disease 2019 in China;Guan;N. Engl. J. Med.,2020

3. Molecular investigation of SARS–CoV-2 proteins and their interactions with antiviral drugs;Calligari;Viruses,2020

4. Pharmacological therapeutics targeting RNA-dependent RNA polymerase, proteinase and spike protein: from mechanistic studies to clinical trials for COVID-19;Huang;J. Clin. Med.,2020

5. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods;Wu;Acta Pharm. Sin. B,2020

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Healing through herbs: everaging herbal remedies against COVID-19;Herbal Formulations, Phytochemistry and Pharmacognosy;2024

2. Exploring the disruption of SARS-CoV-2 RBD binding to hACE2;Frontiers in Chemistry;2023-10-24

3. Investigating theobromine as a potential anti‐human coronaviral agent;Microbiology and Immunology;2023-07-06

4. In Silico Studies of Drug Discovery and Design Against COVID-19 Focusing on ACE2 and Spike Protein Virus Receptors: A Systematic Review;Sciences of Pharmacy;2023-07-06

5. Development of Tyrosine Phosphatase 1B Inhibitors Based on Molecular Docking, Kinetics, and Toxicity Studies;ChemistrySelect;2023-06-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3